TA151 Diabetes - insulin pump therapy: reveiw decision - May 2011
Review of NICE Technology Appraisal Guidance No. 151; Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
The Institute was proposing that the guidance should be transferred to the ‘static guidance list’ for Technology Appraisals.
During consultation, the majority of comments received by the Institute agreed with the proposal put forward. After consideration of all of the comments (attached as appendix A), the Institute’s Guidance Executive has decided to proceed with the proposal.
This page was last updated: 20 May 2011